Trademark Overview
On Wednesday, August 2, 2023, a trademark application was filed for MAGALAB with the United States Patent and Trademark Office. The USPTO has given the MAGALAB trademark a serial number of 98114246. The federal status of this trademark filing is PENDING PETITION/COURT DECISION as of Friday, November 7, 2025. The MAGALAB trademark is filed in the Pharmaceutical Products category with the following description:
Anti-diabetic pharmaceuticals; Antibacterial pharmaceuticals; Cardiovascular pharmaceutical preparations; Cardiovascular pharmaceuticals; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating halitosis; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceuticals, namely, anti-infectives; Pharmaceuticals, namely, antihelmintics; Pharmaceuticals, namely, inducers of erections; Pharmaceuticals, namely, psychotropics